关注
Kyle W Becker
Kyle W Becker
在 vanderbilt.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
D Shae, KW Becker, P Christov, DS Yun, AKR Lytton-Jean, S Sevimli, ...
Nature nanotechnology 14 (3), 269-278, 2019
5182019
Metal limitation and toxicity at the interface between host and pathogen
KW Becker, EP Skaar
FEMS microbiology reviews 38 (6), 1235-1249, 2014
2602014
Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines
D Shae, JJ Baljon, M Wehbe, PP Christov, KW Becker, A Kumar, ...
ACS nano 14 (8), 9904-9916, 2020
1262020
Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells
FC Knight, P Gilchuk, A Kumar, KW Becker, S Sevimli, ME Jacobson, ...
ACS nano 13 (10), 10939-10960, 2019
1082019
Genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii
MI Hood, KW Becker, CM Roux, PM Dunman, EP Skaar
Infection and immunity 81 (2), 542-551, 2013
952013
Poly (propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines
F Qiu, KW Becker, FC Knight, JJ Baljon, S Sevimli, D Shae, P Gilchuk, ...
Biomaterials 182, 82-91, 2018
912018
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration
M Wehbe, L Wang-Bishop, KW Becker, D Shae, JJ Baljon, X He, ...
Journal of Controlled Release 330, 1118-1129, 2021
812021
Delivery of 5′-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy
ME Jacobson, L Wang-Bishop, KW Becker, JT Wilson
Biomaterials science 7 (2), 547-559, 2019
622019
Imaging mass spectrometry for assessing temporal proteomics: Analysis of calprotectin in Acinetobacter baumannii pulmonary infection
JL Moore, KW Becker, JJ Nicklay, KL Boyd, EP Skaar, RM Caprioli
Proteomics 14 (7-8), 820-828, 2014
572014
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
L Wang-Bishop, BR Kimmel, VM Ngwa, MZ Madden, JJ Baljon, ...
Science Immunology 8 (83), eadd1153, 2023
322023
At the bench: Engineering the next generation of cancer vaccines
D Shae, JJ Baljon, M Wehbe, KW Becker, TL Sheehy, JT Wilson
Journal of Leucocyte Biology 108 (4), 1435-1453, 2020
302020
RAGE-mediated suppression of interleukin-10 results in enhanced mortality in a murine model of Acinetobacter baumannii sepsis
MJ Noto, KW Becker, KL Boyd, AM Schmidt, EP Skaar
Infection and immunity 85 (3), 10.1128/iai. 00954-16, 2017
282017
Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists
ME Jacobson, KW Becker, CR Palmer, LE Pastora, RB Fletcher, ...
ACS central science 6 (11), 2008-2022, 2020
252020
A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA
CS Carson, KW Becker, KM Garland, HM Pagendarm, PT Stone, K Arora, ...
Journal of Controlled Release 345, 354-370, 2022
192022
Amphiphilic Polyelectrolyte Graft Copolymers Enhance the Activity of Cyclic Dinucleotide STING Agonists
DC Nguyen, D Shae, HM Pagendarm, KW Becker, M Wehbe, KV Kilchrist, ...
Advanced Healthcare Materials 10 (2), 2001056, 2021
182021
A cancer nanovaccine for co-delivery of peptide neoantigens and optimized combinations of STING and TLR4 agonists
JJ Baljon, AJ Kwiatkowski, HM Pagendarm, PT Stone, A Kumar, V Bharti, ...
ACS nano 18 (9), 6845-6862, 2024
72024
Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy
L Wang-Bishop, M Wehbe, LE Pastora, J Yang, BR Kimmel, KM Garland, ...
ACS nano 18 (18), 11631-11643, 2024
12024
系统目前无法执行此操作,请稍后再试。
文章 1–17